September 30, 2014 - Gallus BioPharmaceuticals, LLC has been acquired by DPx Holdings B.V., privately owned by JLL Partners and Royal DSM and the parent company of Patheon. Patheon’s biologic drug substance business, a unit of DPx Holdings, now spans four global facilities in Europe, Australia and North America and includes more than 550 employees. Please visit the Patheon LinkedIn page to learn more about our expanded capabilities and to follow Patheon. Visit our website at www.Patheon.com
| Website | http://www.patheon.com |
| Revenue | $1.9 billion |
| Employees | 4 (3 on RocketReach) |
| Founded | 2011 |
| Address | 4766 LaGuardia Dr, St. Louis, Missouri 63108, US |
| Industry | Biotechnology Research |
| Keywords | Contract Manufacturing Organization, Pharmaceutical Development, Cmo Services, Pharmaceutical Services, Biopharmaceutical Manufacturing, Biologics Manufacturing, Drug Substance Manufacturing, Drug Product Development, Drug Development Services, Process Development, Pharmaceutical Consulting, Clinical Trial Manufacturing, Api Manufacturing, Sterile Manufacturing, Quality Control, Drug Formulation, Fill Finish Services, Analytical Testing, Regulatory Affairs, Technology Transfer |
| Competitors | Boehringer Ingelheim, Thermo Fisher Scientific, Syneos Health, Catalent Pharma Solutions, Lonza, Charles River Laboratories, Pace Analytical, Merck KGaA, Darmstadt, Germany, Celerion, WuXi AppTec +49 more (view full list) |
Looking for a particular Laureate Biopharmaceutical Services employee's phone or email?
Laureate Biopharmaceutical Services Questions
The Laureate Biopharmaceutical Services annual revenue was $1.9 billion in 2026.
Robert Burford is the VP Regulatory Services of Laureate Biopharmaceutical Services.
3 people are employed at Laureate Biopharmaceutical Services.
Laureate Biopharmaceutical Services is based in St. Louis, Missouri.
Top Laureate Biopharmaceutical Services Employees
Related Companies
